Korean stocks with four straight quarterly losses
Operating loss in each of the last four quarters. Add more filters below to narrow the list.
Add filters earnings · returns · ownership · events · caution · market · industry · sort
Shareholder returns
Ownership
News & events
Caution
Industry
AllElectronics & telecom equipmentMachinery & equipmentPublishing & softwarePharmaceuticalsChemicalsFinancial servicesWholesale tradeMedical, precision & optical instrumentsAutos & auto partsElectrical equipmentBasic metalsResearch & developmentFood productsRubber & plasticsFabricated metal productsFinancial & insurance support servicesRetailGeneral construction
464 Korean listed companies match this signal: operating loss in each of the last four quarters. Based on Q2 2026 reports. 61 are on KOSPI and 403 on KOSDAQ. Sorted by most news articles in the past 24 hours, the list starts with OliX Pharmaceuticals, KMW and Curocell.
4 quarters of losses 464
| Company | Articles 24h | Latest quarter op. profit | Dividend yield | Signals |
|---|---|---|---|---|
| OliX Pharmaceuticals KOSDAQ · Medical & pharmaceutical R&D | 17 | −₩14.0bn | – | Clinical trial filing 4 quarters of losses |
| KMW KOSDAQ · Telecom & broadcasting equipment | 15 | −₩6.3bn | – | Dilution risk 4 quarters of losses |
| Curocell KOSDAQ · Medical & pharmaceutical R&D | 14 | −₩9.7bn | – | Insider buying Clinical trial filing 4 quarters of losses |
| Inventage Lab KOSDAQ · Research & development | 14 | −₩10.3bn | – | Clinical trial filing 4 quarters of losses |
| Satoshi Holdings KOSDAQ · Wholesale trade | 9 | −₩1.6bn | – | 4 quarters of losses |
| CrowdWorks KOSDAQ · Software publishing | 7 | −₩3.6bn | – | Private placement Dilution risk 4 quarters of losses |
| Daekyo KOSPI · Education | 7 | −₩3.7bn | 3.1% | Treasury share sale Swung to loss 4 quarters of losses |
| HLB KOSDAQ · Medical supplies | 7 | −₩22.5bn | – | Revenue +30% 4 quarters of losses |
| CJ Bioscience KOSDAQ · Research & development | 7 | −₩6.4bn | – | 4 quarters of losses |
| Kisco KOSPI · Steel | 6 | −₩6.3bn | 7.4% | Revenue +30% High dividend 4 quarters of losses Dividend cut Share pledge |
| Artist Studio KOSDAQ · Film & video production | 6 | −₩376m | – | Control change Private placement Dilution risk 4 quarters of losses Insider selling |
| KISCO Holdings KOSPI · Steel | 6 | −₩6.8bn | 7.0% | High dividend Dividend grower 4 quarters of losses |
| Focus AI KOSDAQ · Audio & video equipment | 6 | −₩1.2bn | – | Insider buying Major holder adding 4 quarters of losses |
| Ictk KOSDAQ · Semiconductors | 6 | −₩1.9bn | – | 4 quarters of losses |
| AbClon KOSDAQ · Medical supplies | 5 | −₩6.3bn | – | Supply contract Clinical trial filing 4 quarters of losses |
| Prestige Biologics KOSDAQ · Pharmaceuticals | 5 | – | – | Split / consolidation 4 quarters of losses |
| Asiana Airlines KOSPI · Airlines | 5 | −₩356bn | – | 4 quarters of losses Litigation |
| Sigetronics KOSDAQ · Semiconductors | 4 | −₩2.1bn | – | Major holder adding Control change Dilution risk 4 quarters of losses |
| Daegu Department Store KOSPI · Department stores & general retail | 4 | −₩3.9bn | – | 4 quarters of losses Share pledge |
| Chonbang KOSPI · Textiles | 4 | −₩141m | 2.7% | 4 quarters of losses |
| KS Industry KOSDAQ · Special-purpose machinery | 3 | −₩806m | – | Control change Private placement Dilution risk 4 quarters of losses Litigation Delisting / halt risk |
| Zenix Robotics KOSDAQ · Special-purpose machinery | 3 | −₩2.5bn | – | 4 quarters of losses Dividend cut |
| GeneOne Life Science KOSPI · Pharmaceuticals | 3 | −₩12.8bn | – | 4 quarters of losses Litigation |
| Celemics KOSDAQ · Pharmaceutical ingredients | 3 | −₩924m | – | 4 quarters of losses |
| Egis KOSDAQ · Software publishing | 3 | −₩2.4bn | – | 4 quarters of losses |
| Mobiis KOSDAQ · Software development & IT services | 3 | −₩694m | – | 4 quarters of losses |
| Lightron Fiber-optic Devices KOSDAQ · Telecom & broadcasting equipment | 2 | −₩2.1bn | – | Dilution risk 4 quarters of losses Insider selling Share pledge |
| Curiox Biosystems KOSDAQ · Medical devices | 2 | −₩4.5bn | – | Supply contract 4 quarters of losses Insider selling Share pledge |
| Uti KOSDAQ · Electronic components | 2 | −₩15.9bn | – | Private placement Dilution risk 4 quarters of losses |
| Uracle KOSDAQ · Software publishing | 2 | −₩1.1bn | – | Insider buying Major holder adding 4 quarters of losses |
| LabGenomics KOSDAQ · Medical & pharmaceutical R&D | 2 | −₩6.9bn | – | Buyback 4 quarters of losses Delisting / halt risk |
| Cosmo Robotics KOSDAQ · Medical devices | 2 | −₩3.3bn | – | Insider buying 4 quarters of losses Insider selling |
| Astory KOSDAQ · Film & video production | 2 | −₩2.5bn | – | Supply contract 4 quarters of losses |
| GC Cell KOSDAQ · Other professional & technical services | 2 | −₩1.0bn | – | Insider buying 4 quarters of losses |
| Kakao Games KOSDAQ · Software publishing | 2 | −₩23.0bn | – | M&A / stake deal 4 quarters of losses |
| The Codi KOSDAQ · Electronic components | 2 | −₩1.1bn | – | Swung to loss 4 quarters of losses |
| S2W KOSDAQ · Software publishing | 2 | −₩3.2bn | – | Insider buying 4 quarters of losses |
| Lunit KOSDAQ · Software publishing | 2 | −₩15.4bn | – | 4 quarters of losses |
| Maum.ai KOSDAQ · Software publishing | 2 | −₩3.0bn | – | 4 quarters of losses |
| Samwha Electronics KOSPI · Audio & video equipment | 2 | −₩1.5bn | – | 4 quarters of losses |
| Aroot KOSDAQ · Computers & peripherals | 1 | −₩3.4bn | – | Revenue +30% Insider buying Major holder adding M&A / stake deal Private placement Dilution risk 4 quarters of losses Share pledge Delisting / halt risk |
| Ascendio KOSPI · Film & video production | 1 | −₩692m | – | Insider buying New 5% holder Major holder adding Supply contract M&A / stake deal 4 quarters of losses |
| Xplus KOSDAQ · Other manufacturing | 1 | −₩2.3bn | – | New 5% holder Major holder adding Private placement Dilution risk 4 quarters of losses |
| Hyper KOSDAQ · Wholesale trade | 1 | −₩2.5bn | – | Private placement Dilution risk Swung to loss 4 quarters of losses |
| Cellid KOSDAQ · Research & development | 1 | −₩2.5bn | – | Private placement Dilution risk 4 quarters of losses Litigation |
| Lithium-for-earth KOSDAQ · Other manufacturing | 1 | −₩1.3bn | – | Insider buying Private placement Dilution risk 4 quarters of losses |
| RN2 Technologies KOSDAQ · Electronic components | 1 | −₩921m | – | M&A / stake deal 4 quarters of losses Dividend cut Litigation |
| Korea Cable T.V Chung-buk System KOSDAQ · Broadcasting | 1 | −₩738m | – | 4 quarters of losses Litigation Delisting / halt risk |
| HNK Machine Tool KOSDAQ · Special-purpose machinery | 1 | −₩868m | – | Insider buying Supply contract 4 quarters of losses |
| Samyoung S&C KOSDAQ · Electronic components | 1 | −₩407m | – | Insider buying Major holder adding 4 quarters of losses |
| SKC KOSPI · Specialty chemicals | 1 | −₩14.4bn | – | Revenue +30% M&A / stake deal 4 quarters of losses |
| Hanchang KOSPI · Wholesale trade | 1 | −₩1.2bn | – | 4 quarters of losses Litigation Delisting / halt risk |
| Seoul Electronics & Telecom KOSDAQ · Motors, generators & power converters | 1 | −₩782m | – | Control change Swung to loss 4 quarters of losses |
| Twim KOSDAQ · Software publishing | 1 | −₩1.2bn | – | 4 quarters of losses Dividend cut |
| Dx & Vx KOSDAQ · Engineering & technical services | 1 | −₩6.0bn | – | Insider buying 4 quarters of losses |
| SyntekaBio KOSDAQ · Software publishing | 1 | −₩2.2bn | – | Control change 4 quarters of losses |
| Virnect KOSDAQ · Software publishing | 1 | −₩1.8bn | – | Supply contract 4 quarters of losses |
| Sawnics KOSDAQ · Semiconductors | 1 | −₩1.3bn | – | Dilution risk 4 quarters of losses |
| Xavis KOSDAQ · Special-purpose machinery | 1 | −₩675m | – | Swung to loss 4 quarters of losses |
| Zinus KOSPI · Furniture | 1 | −₩26.7bn -192% | 0.7% | Swung to loss 4 quarters of losses |
| Woori Technology KOSDAQ · Motors, generators & power converters | 1 | −₩1.1bn | – | Supply contract 4 quarters of losses |
| SillaJen KOSDAQ · Medical & pharmaceutical R&D | 1 | −₩6.2bn | – | Clinical trial filing 4 quarters of losses |
| Doosan Fuel Cell KOSPI · Motors, generators & power converters | 1 | −₩50.9bn | – | Dilution risk 4 quarters of losses |
| Lincsolution KOSDAQ · Special-purpose machinery | 1 | −₩4.6bn | – | Dilution risk 4 quarters of losses |
| Dragonfly GF KOSDAQ · Software publishing | 1 | −₩279m | – | 4 quarters of losses Delisting / halt risk |
| Medipost KOSDAQ · Pharmaceutical ingredients | 1 | −₩24.3bn | – | M&A / stake deal 4 quarters of losses |
| Hims KOSDAQ · Special-purpose machinery | 1 | −₩3.4bn -336% | – | Swung to loss 4 quarters of losses |
| Vaxcell-Bio Therapeutics KOSDAQ · Medical & pharmaceutical R&D | 1 | −₩5.0bn | – | 4 quarters of losses |
| Keyang Electric Machinery KOSPI · General-purpose machinery | 1 | −₩5.1bn | – | 4 quarters of losses |
| NGeneBio KOSDAQ · Other professional & technical services | 1 | −₩1.2bn | – | 4 quarters of losses |
| Lotte Energy Materials KOSPI · Electronic components | 1 | −₩16.9bn | – | 4 quarters of losses |
| G2gbio KOSDAQ · Pharmaceuticals | 1 | −₩2.7bn | – | 4 quarters of losses |
| Genome&Company KOSDAQ · Pharmaceutical ingredients | 1 | −₩8.0bn | – | 4 quarters of losses |
| Acryl KOSDAQ · Software publishing | 1 | −₩1.5bn | – | 4 quarters of losses |
| LigaChem Biosciences KOSDAQ · Medical & pharmaceutical R&D | 1 | −₩72.0bn | – | 4 quarters of losses |
| Linked KOSDAQ · Electronic components | 1 | −₩2.4bn | – | 4 quarters of losses |
| Genomictree KOSDAQ · Research & development | 1 | −₩2.6bn | – | 4 quarters of losses |
| Carry KOSDAQ · Motors, generators & power converters | 1 | −₩528m | – | 4 quarters of losses |
| Nexa Dynamics KOSDAQ · Special-purpose machinery | 0 | −₩2.6bn | – | Insider buying New 5% holder Major holder adding Stake purpose change Supply contract Asset deal Control change Private placement Dilution risk 4 quarters of losses Insider selling Litigation |
| Beno TNR KOSDAQ · Specialty construction | 0 | −₩1.2bn | – | Insider buying Major holder adding Stake purpose change Supply contract Control change Split / consolidation Swung to loss 4 quarters of losses Insider selling Capital reduction Litigation |
| STX KOSPI · Wholesale trade | 0 | −₩18.9bn | – | Insider buying New 5% holder Major holder adding Control change Private placement Dilution risk 4 quarters of losses Insider selling Capital reduction |
| BK Holdings KOSDAQ · Professional services | 0 | −₩727m | – | Insider buying Major holder adding Control change Private placement Split / consolidation Dilution risk 4 quarters of losses Delisting / halt risk |
| Fine Technix KOSDAQ · Electrical equipment | 0 | −₩2.3bn | – | Insider buying Major holder adding M&A / stake deal Control change Private placement Dilution risk 4 quarters of losses Insider selling |
| Barunson Entertainment & Arts KOSDAQ · Film & video production | 0 | −₩259m | – | Insider buying Major holder adding Private placement Dilution risk Swung to loss 4 quarters of losses Delisting / halt risk |
| E8 KOSDAQ · Software publishing | 0 | −₩2.5bn | – | Supply contract Control change Split / consolidation Dilution risk 4 quarters of losses Insider selling Delisting / halt risk |
| Vect KOSDAQ · Audio & video equipment | 0 | −₩1.7bn | – | Insider buying New 5% holder Major holder adding Stake purpose change Control change 4 quarters of losses Insider selling |
| Mgen Solutions KOSDAQ · Wholesale trade | 0 | −₩2.9bn | – | New 5% holder Major holder adding 4 quarters of losses Litigation Share pledge Delisting / halt risk |
| Csa Cosmic KOSDAQ · Specialty chemicals | 0 | −₩5.7bn | – | Major holder adding M&A / stake deal Split / consolidation Dilution risk 4 quarters of losses Insider selling |
| KNW KOSDAQ · Auto parts | 0 | −₩1.8bn | – | Insider buying New 5% holder Major holder adding Control change 4 quarters of losses Insider selling |
| MOA Life Plus KOSDAQ · Research & development | 0 | −₩1.2bn | – | Control change Private placement Dilution risk 4 quarters of losses Share pledge Delisting / halt risk |
| Aprogen Biologics KOSPI · Pharmaceuticals | 0 | −₩17.5bn | – | Revenue +30% Insider buying Major holder adding 4 quarters of losses Share pledge |
| EcoSimplex KOSDAQ · Facility management | 0 | −₩531m | – | New 5% holder Major holder adding Supply contract Swung to loss 4 quarters of losses |
| Joongang Advanced Materials KOSDAQ · Telecom & broadcasting equipment | 0 | −₩1.0bn | – | Supply contract Control change 4 quarters of losses Insider selling Share pledge |
| Aps KOSDAQ · Other financial services | 0 | −₩3.9bn | – | Insider buying New 5% holder Major holder adding M&A / stake deal 4 quarters of losses |
| Haisung Aero-Robotics KOSDAQ · Fabricated metal products | 0 | −₩736m | – | Control change Swung to loss 4 quarters of losses Litigation Delisting / halt risk |
| Mobile Appliance KOSDAQ · Software publishing | 0 | −₩2.8bn | – | Split / consolidation Swung to loss 4 quarters of losses Litigation Delisting / halt risk |
| Reyon Pharmaceutical KOSPI · Pharmaceuticals | 0 | −₩7.0bn | – | New 5% holder Major holder adding Dilution risk 4 quarters of losses Share pledge |
| OE Solutions KOSDAQ · Telecom & broadcasting equipment | 0 | −₩870m | – | Insider buying Control change 4 quarters of losses Insider selling Share pledge |
| Asta KOSDAQ · Medical supplies | 0 | −₩839m | – | Supply contract Control change Swung to loss 4 quarters of losses Litigation |
| Aribiolab KOSDAQ · Medical & pharmaceutical R&D | 0 | −₩2.5bn | – | Control change Private placement Dilution risk 4 quarters of losses Share pledge |
Signals are generated automatically from DART filings (quarterly results, ownership reports, major-event reports and filing titles) and news counts. Prices and trading flows are not included. Not investment advice.
What this list means
Operating losses in each of the last four quarters. Prolonged losses can be grounds for administrative issue designation on KOSDAQ, with exceptions such as technology-track listings.
Lists are generated automatically from filings and are not investment advice.